中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/28 | 4,451 | 4,712 | 4,446 | 4,617 | +166 | +3.7% | 5,822,300 |
| 2023/09/27 | 4,225 | 4,465 | 4,197 | 4,451 | +174 | +4.1% | 4,190,300 |
| 2023/09/26 | 4,306 | 4,359 | 4,257 | 4,277 | -22 | -0.5% | 1,972,700 |
| 2023/09/25 | 4,288 | 4,331 | 4,259 | 4,299 | +49 | +1.2% | 1,394,200 |
| 2023/09/22 | 4,217 | 4,285 | 4,211 | 4,250 | -15 | -0.4% | 1,874,900 |
| 2023/09/21 | 4,275 | 4,354 | 4,261 | 4,265 | -83 | -1.9% | 1,861,800 |
| 2023/09/20 | 4,435 | 4,454 | 4,337 | 4,348 | -110 | -2.5% | 2,153,700 |
| 2023/09/19 | 4,490 | 4,539 | 4,438 | 4,458 | -69 | -1.5% | 1,603,400 |
| 2023/09/15 | 4,480 | 4,541 | 4,433 | 4,527 | +52 | +1.2% | 2,703,000 |
| 2023/09/14 | 4,526 | 4,535 | 4,441 | 4,475 | -50 | -1.1% | 1,861,500 |
| 2023/09/13 | 4,560 | 4,567 | 4,505 | 4,525 | -23 | -0.5% | 1,350,400 |
| 2023/09/12 | 4,470 | 4,550 | 4,439 | 4,548 | +71 | +1.6% | 1,439,100 |
| 2023/09/11 | 4,458 | 4,485 | 4,419 | 4,477 | +19 | +0.4% | 986,000 |
| 2023/09/08 | 4,470 | 4,513 | 4,437 | 4,458 | -3 | -0.1% | 2,355,200 |
| 2023/09/07 | 4,426 | 4,492 | 4,409 | 4,461 | +30 | +0.7% | 1,360,900 |
| 2023/09/06 | 4,462 | 4,465 | 4,412 | 4,431 | -42 | -0.9% | 1,057,400 |
| 2023/09/05 | 4,440 | 4,473 | 4,420 | 4,473 | +32 | +0.7% | 1,504,700 |
| 2023/09/04 | 4,456 | 4,456 | 4,417 | 4,441 | +26 | +0.6% | 1,183,100 |
| 2023/09/01 | 4,438 | 4,442 | 4,391 | 4,415 | -42 | -0.9% | 1,511,100 |
| 2023/08/31 | 4,415 | 4,493 | 4,395 | 4,457 | +27 | +0.6% | 2,390,400 |
| 2023/08/30 | 4,417 | 4,469 | 4,411 | 4,430 | +20 | +0.5% | 1,475,600 |
| 2023/08/29 | 4,418 | 4,441 | 4,386 | 4,410 | -3 | -0.1% | 1,679,500 |
| 2023/08/28 | 4,372 | 4,422 | 4,367 | 4,413 | +101 | +2.3% | 1,894,600 |
| 2023/08/25 | 4,300 | 4,363 | 4,292 | 4,312 | -15 | -0.3% | 1,765,300 |
| 2023/08/24 | 4,253 | 4,333 | 4,245 | 4,327 | +86 | +2% | 1,773,100 |
| 2023/08/23 | 4,231 | 4,255 | 4,211 | 4,241 | +13 | +0.3% | 1,986,700 |
| 2023/08/22 | 4,237 | 4,255 | 4,211 | 4,228 | ±0 | ±0% | 1,404,300 |
| 2023/08/21 | 4,221 | 4,263 | 4,205 | 4,228 | +13 | +0.3% | 1,793,000 |
| 2023/08/18 | 4,210 | 4,228 | 4,176 | 4,215 | -56 | -1.3% | 1,001,500 |
| 2023/08/17 | 4,238 | 4,296 | 4,238 | 4,271 | -9 | -0.2% | 1,324,400 |
| 2023/08/16 | 4,299 | 4,314 | 4,228 | 4,280 | -8 | -0.2% | 1,322,900 |
| 2023/08/15 | 4,262 | 4,290 | 4,235 | 4,288 | +32 | +0.8% | 739,300 |
| 2023/08/14 | 4,300 | 4,344 | 4,252 | 4,256 | -10 | -0.2% | 1,047,200 |
| 2023/08/10 | 4,197 | 4,281 | 4,185 | 4,266 | +29 | +0.7% | 2,183,700 |
| 2023/08/09 | 4,170 | 4,250 | 4,156 | 4,237 | +55 | +1.3% | 1,664,400 |
| 2023/08/08 | 4,211 | 4,218 | 4,173 | 4,182 | +5 | +0.1% | 1,019,200 |
| 2023/08/07 | 4,109 | 4,180 | 4,096 | 4,177 | +60 | +1.5% | 1,146,100 |
| 2023/08/04 | 4,110 | 4,145 | 4,076 | 4,117 | -35 | -0.8% | 1,741,600 |
| 2023/08/03 | 4,199 | 4,207 | 4,125 | 4,152 | -61 | -1.4% | 1,712,900 |
| 2023/08/02 | 4,280 | 4,312 | 4,205 | 4,213 | -135 | -3.1% | 2,350,400 |
| 2023/08/01 | 4,267 | 4,350 | 4,261 | 4,348 | +117 | +2.8% | 2,654,800 |
| 2023/07/31 | 4,225 | 4,319 | 4,203 | 4,231 | +105 | +2.5% | 4,020,700 |
| 2023/07/28 | 4,052 | 4,145 | 3,990 | 4,126 | +27 | +0.7% | 3,785,500 |
| 2023/07/27 | 4,061 | 4,117 | 4,055 | 4,099 | +54 | +1.3% | 2,496,200 |
| 2023/07/26 | 4,019 | 4,045 | 4,010 | 4,045 | +53 | +1.3% | 1,259,500 |
| 2023/07/25 | 4,055 | 4,070 | 3,939 | 3,992 | -77 | -1.9% | 1,952,600 |
| 2023/07/24 | 4,077 | 4,088 | 4,043 | 4,069 | +62 | +1.5% | 1,678,400 |
| 2023/07/21 | 3,982 | 4,026 | 3,958 | 4,007 | +55 | +1.4% | 1,594,700 |
| 2023/07/20 | 3,961 | 3,969 | 3,932 | 3,952 | -11 | -0.3% | 1,848,500 |
| 2023/07/19 | 3,948 | 3,963 | 3,922 | 3,963 | +55 | +1.4% | 1,775,700 |
451～
500
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 734,000円 | +1.7% | +5.0% | 3.41% | 29.46倍 | 6.08倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 367,800円 | +6.0% | +4.0% | 2.12% | 22.84倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 421,700円 | -1.1% | +75.3% | 4.74% | 29.21倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 745,800円 | +2.2% | +28.0% | 1.88% | 11.94倍 | 1.45倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 157,600円 | +0.9% | +380.2% | 4.95% | 21.71倍 | 1.87倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
